One in 10 Americans live with a rare disease, which often lacks effective treatments. Such is the case for PIGA-CDG, an ultra ...
In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches -- gene therapy and bone marrow transplantation – to alleviate symptoms of multiple ...
We are a discovery engine and have a pretty good track record for multiple indications including numerous neurological compounds in preclinical studies and even a couple in the clinic for ultra-rare ...
Meanwhile, NICE’s system for ultra-orphan drugs ... webinar brought together some of the key stakeholders in rare disease market access to discuss the changes, and see how all sides can work ...
is undoubtedly the biggest issue for Vimizim and other rare and ultra-rare disease treatments. BioMarin has already offered a confidential 'patient access scheme' (PAS) discount to the £394,680 ...
1d
Hosted on MSNUltragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/YUltragenyx Pharmaceutical RARE reported fourth-quarter 2024 loss of $1.39 per share, wider than the Zacks Consensus Estimate ...
The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...
Families of rare disease patients appeal to PM Modi and Health Minister for increased treatment funding support.
Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative Medicine (CIRM) to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results